New evidence emerges for use of anti-inflammatory therapy for prevention of recurrent vascular events in stroke Dr. Kamal Kant Kohli12 Jun 2024 9:45 PM ISTIn the international CONVINCE trial, presented today at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with...
Limiting hematoma growth may improve mortality in anticoagulant-related intracerebral haemorrhage patients: Study Dr. Kamal Kant Kohli7 Jun 2024 8:00 PM ISTA secondary analysis of ANNEXa-I, presented today at the European Stroke Organisation Conference (ESOC) 2024, showed the clinical consequences of...
Tactical training to revolutionize access to acute stroke treatment in regional Australia: results fromTACTICS Trial Dr. Kamal Kant Kohli2 Jun 2024 9:30 PM ISTTACTICS, a non-randomised intervention trial that aimed to optimsze workflow and implement specialized imaging, has shown promise in improving access...
Perispinal administration of etanercept may not improve quality of life in chronic stroke patients, claims research Dr. Kamal Kant Kohli30 May 2024 8:00 PM ISTAn international study has found no evidence to support use of an arthritis medication sometimes prescribed 'off-label' to patients living with the...
TASTE trial results support use of tenecteplase for acute ischaemic stroke within 4.5 hours based on perfusion imaging Dr. Kamal Kant Kohli28 May 2024 8:30 PM ISTIn the international TASTE trial, the intention-to- treat analysis narrowly failed to demonstrate non-inferiority of tenecteplase compared to...
Glibenclamide, a drug targeting cerebral edema, did not improve functional outcome in severe stroke patients: Study Dr. Kamal Kant Kohli28 May 2024 2:00 AM ISTIntravenous glibenclamide, a drug capable of reducing cerebral edema, did not improve functional outcome at three months in patients with large...
